VHT holdings - what the fund actually owns
VANGUARD HEALTH CARE INDEX FUND reports 396 stock positions to the SEC, 100% of its assets. The ten largest are 51.9% of the fund, as of May 31, 2026.
Each week Ploutos reads the latest N-PORT filing of the largest US equity ETFs. This page is one fund's filing: its reported positions with their weights, where that weight sits by sector, what entered and left since the previous filing, and which other funds hold the most of the same stocks.
Reported positions
396
cover 100% of the fund
Weight of the top 10 holdings
51.9%
of the fund in ten names
Largest position
LLY
14.04% · Eli Lilly & Co
Filing date
May 31, 2026
holdings as reported to the SEC
Where the weight sits, by sector
Healthcare
98.8%
Technology
0.3%
Financial Services
0.1%
Industrials
0.1%
Basic Materials
0.0%
Unknown
0.5%
Sectors come from each company's industry code in its SEC record, so they are coarse. 0.5% of the reported weight could not be placed and is shown as unknown.
Full holdings list, heaviest first
| # | Stock | Weight | Cumulative |
|---|---|---|---|
| 1 | LLYEli Lilly & Co | 14.04% | 14.0% |
| 2 | JNJJohnson & Johnson | 8.47% | 22.5% |
| 3 | ABBVAbbVie Inc | 6.09% | 28.6% |
| 4 | UNHUnitedHealth Group Inc | 5.45% | 34.0% |
| 5 | MRKMerck & Co Inc | 4.66% | 38.7% |
| 6 | TMOThermo Fisher Scientific Inc | 2.93% | 41.6% |
| 7 | AMGNAmgen Inc | 2.87% | 44.5% |
| 8 | GILDGilead Sciences Inc | 2.64% | 47.1% |
| 9 | ISRGIntuitive Surgical Inc | 2.38% | 49.5% |
| 10 | PFEPfizer Inc | 2.35% | 51.9% |
| 11 | ABTAbbott Laboratories | 2.35% | 54.2% |
| 12 | BMYBristol-Myers Squibb Co | 1.84% | 56.1% |
| 13 | DHRDanaher Corp | 1.84% | 57.9% |
| 14 | CVSCVS Health Corp | 1.83% | 59.7% |
| 15 | VRTXVertex Pharmaceuticals Inc | 1.80% | 61.5% |
| 16 | SYKStryker Corp | 1.66% | 63.2% |
| 17 | MDTMedtronic PLC | 1.50% | 64.7% |
| 18 | MCKMcKesson Corp | 1.45% | 66.1% |
| 19 | ELVElevance Health Inc | 1.35% | 67.5% |
| 20 | CICigna Group/The | 1.17% | 68.7% |
| 21 | BSXBoston Scientific Corp | 1.13% | 69.8% |
| 22 | REGNRegeneron Pharmaceuticals Inc | 1.00% | 70.8% |
| 23 | HCAHCA Healthcare Inc | 0.96% | 71.8% |
| 24 | EWEdwards Lifesciences Corp | 0.79% | 72.5% |
| 25 | CORCencora Inc | 0.79% | 73.3% |
| 26 | CAHCardinal Health Inc | 0.74% | 74.1% |
| 27 | IDXXIDEXX Laboratories Inc | 0.71% | 74.8% |
| 28 | BDXBecton Dickinson & Co | 0.66% | 75.4% |
| 29 | ALNYAlnylam Pharmaceuticals Inc | 0.63% | 76.1% |
| 30 | AAgilent Technologies Inc | 0.61% | 76.7% |
| 31 | WATWaters Corp | 0.60% | 77.3% |
| 32 | HUMHumana Inc | 0.58% | 77.9% |
| 33 | ZTSZoetis Inc | 0.54% | 78.4% |
| 34 | IQVIQVIA Holdings Inc | 0.49% | 78.9% |
| 35 | NTRANatera Inc | 0.46% | 79.4% |
| 36 | CNCCentene Corp | 0.46% | 79.8% |
| 37 | BIIBBiogen Inc | 0.46% | 80.3% |
| 38 | DXCMDexcom Inc | 0.46% | 80.7% |
| 39 | GEHCGE HealthCare Technologies Inc | 0.45% | 81.2% |
| 40 | RMDResMed Inc | 0.44% | 81.6% |
| 41 | VEEVVeeva Systems Inc | 0.43% | 82.1% |
| 42 | RVMDREVOLUTION Medicines Inc | 0.40% | 82.5% |
| 43 | ILMNIllumina Inc | 0.39% | 82.9% |
| 44 | MTDMettler-Toledo International Inc | 0.38% | 83.2% |
| 45 | WSTWest Pharmaceutical Services Inc | 0.37% | 83.6% |
| 46 | INSMInsmed Inc | 0.36% | 84.0% |
| 47 | UTHRUnited Therapeutics Corp | 0.36% | 84.3% |
| 48 | DGXQuest Diagnostics Inc | 0.34% | 84.7% |
| 49 | LHLabcorp Holdings Inc | 0.34% | 85.0% |
| 50 | STESTERIS PLC | 0.33% | 85.3% |
| 51 | VTRSViatris Inc | 0.30% | 85.6% |
| 52 | ZBHZimmer Biomet Holdings Inc | 0.26% | 85.9% |
| 53 | INCYIncyte Corp | 0.26% | 86.1% |
| 54 | NBIXNeurocrine Biosciences Inc | 0.25% | 86.4% |
| 55 | THCTenet Healthcare Corp | 0.24% | 86.6% |
| 56 | GHGuardant Health Inc | 0.23% | 86.9% |
| 57 | MRNAModerna Inc | 0.23% | 87.1% |
| 58 | JAZZJazz Pharmaceuticals PLC | 0.20% | 87.3% |
| 59 | EXELExelixis Inc | 0.20% | 87.5% |
| 60 | COOCooper Cos Inc/The | 0.19% | 87.7% |
| 61 | ALGNAlign Technology Inc | 0.19% | 87.9% |
| 62 | RVTYRevvity Inc | 0.19% | 88.1% |
| 63 | ELANElanco Animal Health Inc | 0.19% | 88.3% |
| 64 | PENPenumbra Inc | 0.19% | 88.4% |
| 65 | IONSIonis Pharmaceuticals Inc | 0.19% | 88.6% |
| 66 | SOLVSolventum Corp | 0.19% | 88.8% |
| 67 | ROIVRoivant Sciences Ltd | 0.18% | 89.0% |
| 68 | EHCEncompass Health Corp | 0.17% | 89.2% |
| 69 | BMRNBioMarin Pharmaceutical Inc | 0.17% | 89.3% |
| 70 | PODDInsulet Corp | 0.16% | 89.5% |
| 71 | MEDPMedpace Holdings Inc | 0.16% | 89.6% |
| 72 | ENSGEnsign Group Inc/The | 0.15% | 89.8% |
| 73 | BAXBaxter International Inc | 0.15% | 90.0% |
| 74 | BBIOBridgebio Pharma Inc | 0.15% | 90.1% |
| 75 | ARWRArrowhead Pharmaceuticals Inc | 0.15% | 90.3% |
| 76 | MDLNMedline Inc | 0.15% | 90.4% |
| 77 | GMEDGlobus Medical Inc | 0.15% | 90.6% |
| 78 | CYTKCytokinetics Inc | 0.14% | 90.7% |
| 79 | MOHMolina Healthcare Inc | 0.14% | 90.8% |
| 80 | CRLCharles River Laboratories International Inc | 0.14% | 91.0% |
| 81 | BTSGBrightSpring Health Services Inc | 0.14% | 91.1% |
| 82 | PRAXPraxis Precision Medicines Inc | 0.13% | 91.2% |
| 83 | AXSMAxsome Therapeutics Inc | 0.13% | 91.4% |
| 84 | MASIMO CORP | 0.13% | 91.5% |
| 85 | HSICHenry Schein Inc | 0.13% | 91.6% |
| 86 | UHSUniversal Health Services Inc | 0.13% | 91.8% |
| 87 | TECHBio-Techne Corp | 0.13% | 91.9% |
| 88 | HALOHalozyme Therapeutics Inc | 0.12% | 92.0% |
| 89 | DVADaVita Inc | 0.12% | 92.1% |
| 90 | HQYHealthEquity Inc | 0.12% | 92.3% |
| 91 | MDGLMadrigal Pharmaceuticals Inc | 0.12% | 92.4% |
| 92 | KRYSKrystal Biotech Inc | 0.11% | 92.5% |
| 93 | RGENRepligen Corp | 0.10% | 92.6% |
| 94 | ALKSAlkermes PLC | 0.10% | 92.7% |
| 95 | LNTHLantheus Holdings Inc | 0.10% | 92.8% |
| 96 | CORTCorcept Therapeutics Inc | 0.10% | 92.9% |
| 97 | BRKRBruker Corp | 0.10% | 93.0% |
| 98 | AVTRAvantor Inc | 0.10% | 93.1% |
| 99 | PCVXVaxcyte Inc | 0.10% | 93.2% |
| 100 | CHEChemed Corp | 0.10% | 93.3% |
| 101 | GKOSGlaukos Corp | 0.09% | 93.4% |
| 102 | BIOBio-Rad Laboratories Inc | 0.09% | 93.5% |
| 103 | TGTXTG Therapeutics Inc | 0.09% | 93.6% |
| 104 | TFXTeleflex Inc | 0.09% | 93.6% |
| 105 | PTCTPTC Therapeutics Inc | 0.08% | 93.7% |
| 106 | HIMSHims & Hers Health Inc | 0.08% | 93.8% |
| 107 | RYTMRhythm Pharmaceuticals Inc | 0.08% | 93.9% |
| 108 | PTGXProtagonist Therapeutics Inc | 0.08% | 94.0% |
| 109 | TEMTempus AI Inc | 0.07% | 94.0% |
| 110 | LGNDLigand Pharmaceuticals Inc | 0.07% | 94.1% |
| 111 | NUNuvalent Inc | 0.07% | 94.2% |
| 112 | SHCSotera Health Co | 0.07% | 94.3% |
| 113 | LIVNLivaNova PLC | 0.06% | 94.3% |
| 114 | TWSTTwist Bioscience Corp | 0.06% | 94.4% |
| 115 | TVTXTravere Therapeutics Inc | 0.06% | 94.4% |
| 116 | NVSTEnvista Holdings Corp | 0.06% | 94.5% |
| 117 | KYMRKymera Therapeutics Inc | 0.06% | 94.6% |
| 118 | MIRMMirum Pharmaceuticals Inc | 0.06% | 94.6% |
| 119 | INDVIndivior Pharmaceuticals Inc | 0.06% | 94.7% |
| 120 | LQDALiquidia Corp | 0.06% | 94.7% |
| 121 | MMSIMerit Medical Systems Inc | 0.06% | 94.8% |
| 122 | IRTCIRhythm Holdings Inc | 0.06% | 94.9% |
| 123 | RDNTRadNet Inc | 0.06% | 94.9% |
| 124 | VCYTVeracyte Inc | 0.06% | 95.0% |
| 125 | CATALYST PHARMACEUTICALS INC | 0.06% | 95.0% |
| 126 | SYRESpyre Therapeutics Inc | 0.06% | 95.1% |
| 127 | VKTXViking Therapeutics Inc | 0.06% | 95.2% |
| 128 | OGNOrganon & Co | 0.05% | 95.2% |
| 129 | OPCHOption Care Health Inc | 0.05% | 95.3% |
| 130 | DNTHDianthus Therapeutics Inc | 0.05% | 95.3% |
| 131 | CRINETICS PHARMACEUTICALS INC | 0.05% | 95.4% |
| 132 | ICUIICU Medical Inc | 0.05% | 95.4% |
| 133 | HAEHaemonetics Corp | 0.05% | 95.5% |
| 134 | APOGEE THERAPEUTICS INC | 0.05% | 95.5% |
| 135 | ITGRInteger Holdings Corp | 0.05% | 95.6% |
| 136 | SRRKScholar Rock Holding Corp | 0.05% | 95.6% |
| 137 | BEAMBeam Therapeutics Inc | 0.05% | 95.7% |
| 138 | TXG10X Genomics Inc | 0.05% | 95.7% |
| 139 | COGTCogent Biosciences Inc | 0.05% | 95.8% |
| 140 | DNLIDenali Therapeutics Inc | 0.05% | 95.8% |
| 141 | BKDBrookdale Senior Living Inc | 0.05% | 95.8% |
| 142 | CONConcentra Group Holdings Parent Inc | 0.05% | 95.9% |
| 143 | CELCCelcuity Inc | 0.04% | 95.9% |
| 144 | SMMTSummit Therapeutics Inc | 0.04% | 96.0% |
| 145 | IMVTImmunovant Inc | 0.04% | 96.0% |
| 146 | CGONCG oncology Inc | 0.04% | 96.1% |
| 147 | DOCSDoximity Inc | 0.04% | 96.1% |
| 148 | SUPNSupernus Pharmaceuticals Inc | 0.04% | 96.1% |
| 149 | IBRXImmunityBio Inc | 0.04% | 96.2% |
| 150 | ACADACADIA Pharmaceuticals Inc | 0.04% | 96.2% |
| 151 | ALHCAlignment Healthcare Inc | 0.04% | 96.3% |
| 152 | GRALGRAIL Inc | 0.04% | 96.3% |
| 153 | NHCNational HealthCare Corp | 0.04% | 96.3% |
| 154 | ARQTArcutis Biotherapeutics Inc | 0.04% | 96.4% |
| 155 | IDYAIdeaya Biosciences Inc | 0.04% | 96.4% |
| 156 | PBHPrestige Consumer Healthcare Inc | 0.04% | 96.5% |
| 157 | WAYWaystar Holding Corp | 0.04% | 96.5% |
| 158 | DYNDyne Therapeutics Inc | 0.04% | 96.5% |
| 159 | RCUSArcus Biosciences Inc | 0.03% | 96.6% |
| 160 | ERASErasca Inc | 0.03% | 96.6% |
| 161 | TMDXTransMedics Group Inc | 0.03% | 96.6% |
| 162 | PRVAPrivia Health Group Inc | 0.03% | 96.7% |
| 163 | CLDXCelldex Therapeutics Inc | 0.03% | 96.7% |
| 164 | PGNYProgyny Inc | 0.03% | 96.7% |
| 165 | AMRXAmneal Pharmaceuticals Inc | 0.03% | 96.8% |
| 166 | XRAYDENTSPLY SIRONA Inc | 0.03% | 96.8% |
| 167 | RAREUltragenyx Pharmaceutical Inc | 0.03% | 96.8% |
| 168 | IMNMImmunome Inc | 0.03% | 96.9% |
| 169 | ACHCAcadia Healthcare Co Inc | 0.03% | 96.9% |
| 170 | LMATLeMaitre Vascular Inc | 0.03% | 96.9% |
| 171 | NKTRNektar Therapeutics | 0.03% | 97.0% |
| 172 | OMCLOmnicell Inc | 0.03% | 97.0% |
| 173 | DFTXDefinium Therapeutics Inc | 0.03% | 97.0% |
| 174 | TARSTarsus Pharmaceuticals Inc | 0.03% | 97.0% |
| 175 | ADMAADMA Biologics Inc | 0.03% | 97.1% |
| 176 | CRVLCorVel Corp | 0.03% | 97.1% |
| 177 | NEOGNeogen Corp | 0.03% | 97.1% |
| 178 | BCRXBioCryst Pharmaceuticals Inc | 0.03% | 97.2% |
| 179 | MDPediatrix Medical Group Inc | 0.03% | 97.2% |
| 180 | SELECT MEDICAL HOLDINGS CORP | 0.03% | 97.2% |
| 181 | ORKAOruka Therapeutics Inc | 0.03% | 97.3% |
| 182 | AXGNAxogen Inc | 0.03% | 97.3% |
| 183 | EWTXEdgewise Therapeutics Inc | 0.03% | 97.3% |
| 184 | NVCRNovocure Ltd | 0.03% | 97.3% |
| 185 | NTLAIntellia Therapeutics Inc | 0.03% | 97.4% |
| 186 | RLAYRelay Therapeutics Inc | 0.03% | 97.4% |
| 187 | SRPTSarepta Therapeutics Inc | 0.03% | 97.4% |
| 188 | KNSAKiniksa Pharmaceuticals International Plc | 0.03% | 97.5% |
| 189 | ADPTAdaptive Biotechnologies Corp | 0.03% | 97.5% |
| 190 | PACSPACS Group Inc | 0.03% | 97.5% |
| 191 | AUPHAurinia Pharmaceuticals Inc | 0.03% | 97.5% |
| 192 | ADUSAddus HomeCare Corp | 0.03% | 97.6% |
| 193 | ASTHAstrana Health Inc | 0.03% | 97.6% |
| 194 | CLOVClover Health Investments Corp | 0.03% | 97.6% |
| 195 | IRONDisc Medicine Inc | 0.03% | 97.6% |
| 196 | VCELVericel Corp | 0.03% | 97.7% |
| 197 | AGIOAgios Pharmaceuticals Inc | 0.03% | 97.7% |
| 198 | UFPTUFP Technologies Inc | 0.03% | 97.7% |
| 199 | SNDXSyndax Pharmaceuticals Inc | 0.03% | 97.7% |
| 200 | RXRXRecursion Pharmaceuticals Inc | 0.03% | 97.8% |
| 201 | PRGOPerrigo Co PLC | 0.02% | 97.8% |
| 202 | INVAInnoviva Inc | 0.02% | 97.8% |
| 203 | NAMSNewamsterdam Pharma Co NV | 0.02% | 97.8% |
| 204 | NVAXNovavax Inc | 0.02% | 97.9% |
| 205 | PRCTProcept Biorobotics Corp | 0.02% | 97.9% |
| 206 | ARDXArdelyx Inc | 0.02% | 97.9% |
| 207 | MLYSMineralys Therapeutics Inc | 0.02% | 97.9% |
| 208 | OCULOcular Therapeutix Inc | 0.02% | 98.0% |
| 209 | BHVNBiohaven Ltd | 0.02% | 98.0% |
| 210 | FTREFortrea Holdings Inc | 0.02% | 98.0% |
| 211 | ANIPANI Pharmaceuticals Inc | 0.02% | 98.0% |
| 212 | ALMSAlumis Inc | 0.02% | 98.0% |
| 213 | ATRCAtriCure Inc | 0.02% | 98.1% |
| 214 | HRMYHarmony Biosciences Holdings Inc | 0.02% | 98.1% |
| 215 | NEONeoGenomics Inc | 0.02% | 98.1% |
| 216 | VERAVera Therapeutics Inc | 0.02% | 98.1% |
| 217 | NRIXNurix Therapeutics Inc | 0.02% | 98.2% |
| 218 | TRVITrevi Therapeutics Inc | 0.02% | 98.2% |
| 219 | LFSTLifeStance Health Group Inc | 0.02% | 98.2% |
| 220 | TDOCTeladoc Health Inc | 0.02% | 98.2% |
| 221 | ENOVEnovis Corp | 0.02% | 98.2% |
| 222 | ELVNEnliven Therapeutics Inc | 0.02% | 98.3% |
| 223 | IOVAIovance Biotherapeutics Inc | 0.02% | 98.3% |
| 224 | ESTAEstablishment Labs Holdings Inc | 0.02% | 98.3% |
| 225 | STOKStoke Therapeutics Inc | 0.02% | 98.3% |
| 226 | PNTGPennant Group Inc/The | 0.02% | 98.3% |
| 227 | INSPInspire Medical Systems Inc | 0.02% | 98.4% |
| 228 | TNDMTandem Diabetes Care Inc | 0.02% | 98.4% |
| 229 | AVANOS MEDICAL INC | 0.02% | 98.4% |
| 230 | CDNACareDx Inc | 0.02% | 98.4% |
| 231 | PIERIS PHARMACEUTICALS INC | 0.02% | 98.4% |
| 232 | AGLagilon health Inc | 0.02% | 98.4% |
| 233 | VRDNViridian Therapeutics Inc | 0.02% | 98.5% |
| 234 | RAPPRapport Therapeutics Inc | 0.02% | 98.5% |
| 235 | VIRVir Biotechnology Inc | 0.02% | 98.5% |
| 236 | AMNAMN Healthcare Services Inc | 0.02% | 98.5% |
| 237 | CNMDCONMED Corp | 0.02% | 98.5% |
| 238 | HROWHarrow Inc | 0.02% | 98.6% |
| 239 | URGNUroGen Pharma Ltd | 0.02% | 98.6% |
| 240 | MNKDMannKind Corp | 0.02% | 98.6% |
| 241 | COLLCollegium Pharmaceutical Inc | 0.02% | 98.6% |
| 242 | KODKodiak Sciences Inc | 0.02% | 98.6% |
| 243 | IARTIntegra LifeSciences Holdings Corp | 0.02% | 98.6% |
| 244 | NUVBNuvation Bio Inc | 0.02% | 98.7% |
| 245 | WGSGeneDx Holdings Corp | 0.02% | 98.7% |
| 246 | SGRYSurgery Partners Inc | 0.02% | 98.7% |
| 247 | XERSXeris Biopharma Holdings Inc | 0.02% | 98.7% |
| 248 | BIOLIFE SOLUTIONS INC | 0.02% | 98.7% |
| 249 | EYPTEyePoint Inc | 0.02% | 98.7% |
| 250 | SDGRSchrodinger Inc/United States | 0.02% | 98.8% |
| 251 | NEW ISSUER: BB COMPANY ID:54419104 | 0.02% | 98.8% |
| 252 | TNGXTango Therapeutics Inc | 0.02% | 98.8% |
| 253 | USPHUS Physical Therapy Inc | 0.02% | 98.8% |
| 254 | STAASTAAR Surgical Co | 0.02% | 98.8% |
| 255 | AHCOAdaptHealth Corp | 0.02% | 98.8% |
| 256 | AZTAAzenta Inc | 0.02% | 98.8% |
| 257 | AMLXAmylyx Pharmaceuticals Inc | 0.02% | 98.9% |
| 258 | PCRXPacira BioSciences Inc | 0.02% | 98.9% |
| 259 | NEW ISSUER: BB COMPANY ID:69588108 | 0.01% | 98.9% |
| 260 | ZYMEZymeworks Inc | 0.01% | 98.9% |
| 261 | ATECAlphatec Holdings Inc | 0.01% | 98.9% |
| 262 | BFLYButterfly Network Inc | 0.01% | 98.9% |
| 263 | AORTArtivion Inc | 0.01% | 98.9% |
| 264 | QDELQuidelOrtho Corp | 0.01% | 99.0% |
| 265 | TSHATaysha Gene Therapies Inc | 0.01% | 99.0% |
| 266 | KURAKura Oncology Inc | 0.01% | 99.0% |
| 267 | OMEROmeros Corp | 0.01% | 99.0% |
| 268 | ANABAnaptysBio Inc | 0.01% | 99.0% |
| 269 | PGENPrecigen Inc | 0.01% | 99.0% |
| 270 | ESPERION THERAPEUTICS INC | 0.01% | 99.0% |
| 271 | IRMDiRadimed Corp | 0.01% | 99.0% |
| 272 | CYRXCryoPort Inc | 0.01% | 99.1% |
| 273 | KALVISTA PHARMACEUTICALS INC | 0.01% | 99.1% |
| 274 | TALKSPACE INC | 0.01% | 99.1% |
| 275 | WVEWaVe Life Sciences Ltd | 0.01% | 99.1% |
| 276 | MBXMBX Biosciences Inc | 0.01% | 99.1% |
| 277 | AMPHAmphastar Pharmaceuticals Inc | 0.01% | 99.1% |
| 278 | AURAAura Biosciences Inc | 0.01% | 99.1% |
| 279 | CERTCertara Inc | 0.01% | 99.1% |
| 280 | CRVSCorvus Pharmaceuticals Inc | 0.01% | 99.1% |
| 281 | ABUSArbutus Biopharma Corp | 0.01% | 99.2% |
| 282 | ANNXAnnexon Inc | 0.01% | 99.2% |
| 283 | TLRYTilray Brands Inc | 0.01% | 99.2% |
| 284 | AVBPArriVent Biopharma Inc | 0.01% | 99.2% |
| 285 | PAHCPhibro Animal Health Corp | 0.01% | 99.2% |
| 286 | CRMDCorMedix Inc | 0.01% | 99.2% |
| 287 | OPKOPKO Health Inc | 0.01% | 99.2% |
| 288 | CSTLCastle Biosciences Inc | 0.01% | 99.2% |
| 289 | GLUEMonte Rosa Therapeutics Inc | 0.01% | 99.2% |
| 290 | MLTXMoonLake Immunotherapeutics | 0.01% | 99.2% |
| 291 | THERAVANCE BIOPHARMA INC | 0.01% | 99.3% |
| 292 | BCAXBicara Therapeutics Inc | 0.01% | 99.3% |
| 293 | PSNLPersonalis Inc | 0.01% | 99.3% |
| 294 | GERNGeron Corp | 0.01% | 99.3% |
| 295 | HSTMHealthStream Inc | 0.01% | 99.3% |
| 296 | PHRPhreesia Inc | 0.01% | 99.3% |
| 297 | CERSCerus Corp | 0.01% | 99.3% |
| 298 | XNCRXencor Inc | 0.01% | 99.3% |
| 299 | SIBNSI-BONE Inc | 0.01% | 99.3% |
| 300 | ALTAltimmune Inc | 0.01% | 99.3% |
| 301 | CTMXCytomX Therapeutics Inc | 0.01% | 99.4% |
| 302 | JANXJanux Therapeutics Inc | 0.01% | 99.4% |
| 303 | SANASana Biotechnology Inc | 0.01% | 99.4% |
| 304 | MLABMesa Laboratories Inc | 0.01% | 99.4% |
| 305 | TCMDTactile Systems Technology Inc | 0.01% | 99.4% |
| 306 | ALLOAllogene Therapeutics Inc | 0.01% | 99.4% |
| 307 | IRWDIronwood Pharmaceuticals Inc | 0.01% | 99.4% |
| 308 | MRVIMaravai LifeSciences Holdings Inc | 0.01% | 99.4% |
| 309 | PLSEPulse Biosciences Inc | 0.01% | 99.4% |
| 310 | OLMAOlema Pharmaceuticals Inc | 0.01% | 99.4% |
| 311 | ARVNArvinas Inc | 0.01% | 99.4% |
| 312 | SPRYARS Pharmaceuticals Inc | 0.01% | 99.4% |
| 313 | CGEMCullinan Therapeutics Inc | 0.01% | 99.4% |
| 314 | EBSEmergent BioSolutions Inc | 0.01% | 99.5% |
| 315 | ANGOAngioDynamics Inc | 0.01% | 99.5% |
| 316 | MGTXMeiraGTx Holdings plc | 0.01% | 99.5% |
| 317 | PRTAProthena Corp PLC | 0.01% | 99.5% |
| 318 | CTKBCytek Biosciences Inc | 0.01% | 99.5% |
| 319 | PHATPhathom Pharmaceuticals Inc | 0.01% | 99.5% |
| 320 | TYRATyra Biosciences Inc | 0.01% | 99.5% |
| 321 | KMTSKestra Medical Technologies In | 0.01% | 99.5% |
| 322 | MDXGMiMedx Group Inc | 0.01% | 99.5% |
| 323 | OCGNOcugen Inc | 0.01% | 99.5% |
| 324 | VREXVarex Imaging Corp | 0.01% | 99.5% |
| 325 | FDMT4D Molecular Therapeutics Inc | 0.01% | 99.5% |
| 326 | XOMA ROYALTY CORP | 0.01% | 99.5% |
| 327 | REPLReplimune Group Inc | 0.01% | 99.5% |
| 328 | LXRXLexicon Pharmaceuticals Inc | 0.01% | 99.6% |
| 329 | CROSS COUNTRY HEALTHCARE INC | 0.01% | 99.6% |
| 330 | CATXPerspective Therapeutics Inc | 0.01% | 99.6% |
| 331 | PACBPacific Biosciences of California Inc | 0.01% | 99.6% |
| 332 | AVAHAveanna Healthcare Holdings Inc | 0.01% | 99.6% |
| 333 | EVHEvolent Health Inc | 0.01% | 99.6% |
| 334 | MYGNMyriad Genetics Inc | 0.01% | 99.6% |
| 335 | ORICORIC Pharmaceuticals Inc | 0.01% | 99.6% |
| 336 | FLGTFulgent Genetics Inc | 0.01% | 99.6% |
| 337 | VNDAVanda Pharmaceuticals Inc | 0.01% | 99.6% |
| 338 | SVRASavara Inc | 0.01% | 99.6% |
| 339 | BVSBioventus Inc | 0.01% | 99.6% |
| 340 | CYHCommunity Health Systems Inc | 0.01% | 99.6% |
| 341 | CBLLCeribell Inc | 0.01% | 99.6% |
| 342 | EDITEditas Medicine Inc | 0.01% | 99.6% |
| 343 | SEPNSepterna Inc | 0.01% | 99.6% |
| 344 | DNAGinkgo Bioworks Holdings Inc | 0.01% | 99.6% |
| 345 | EOLSEvolus Inc | 0.01% | 99.6% |
| 346 | PRMEPrime Medicine Inc | 0.01% | 99.7% |
| 347 | RGNXREGENXBIO Inc | <0.01% | 99.7% |
| 348 | KIDSOrthoPediatrics Corp | <0.01% | 99.7% |
| 349 | SIMULATIONS PLUS INC | <0.01% | 99.7% |
| 350 | OFIXOrthofix Medical Inc | <0.01% | 99.7% |
| 351 | ZBIOZenas Biopharma Inc | <0.01% | 99.7% |
| 352 | LABStandard BioTools Inc | <0.01% | 99.7% |
| 353 | FATEFate Therapeutics Inc | <0.01% | 99.7% |
| 354 | OSUROraSure Technologies Inc | <0.01% | 99.7% |
| 355 | AVXLAnavex Life Sciences Corp | <0.01% | 99.7% |
| 356 | ARDTArdent Health Partners Inc | <0.01% | 99.7% |
| 357 | FULCFulcrum Therapeutics Inc | <0.01% | 99.7% |
| 358 | AKBAAkebia Therapeutics Inc | <0.01% | 99.7% |
| 359 | GDRXGoodRx Holdings Inc | <0.01% | 99.7% |
| 360 | RCKTRocket Pharmaceuticals Inc | <0.01% | 99.7% |
| 361 | AVIRAtea Pharmaceuticals Inc | <0.01% | 99.7% |
| 362 | RZLTRezolute Inc | <0.01% | 99.7% |
| 363 | OABIOmniAb Inc | <0.01% | 99.7% |
| 364 | TRAXFirst Tracks Biotherapeutics Inc | <0.01% | 99.7% |
| 365 | QSIQuantum-Si Inc | <0.01% | 99.7% |
| 366 | ARCTArcturus Therapeutics Holdings Inc | <0.01% | 99.7% |
| 367 | HUMAHumacyte Inc | <0.01% | 99.7% |
| 368 | MGNXMacroGenics Inc | <0.01% | 99.7% |
| 369 | SIGASIGA Technologies Inc | <0.01% | 99.7% |
| 370 | UPBUpstream Bio Inc | <0.01% | 99.7% |
| 371 | ZNTLZentalis Pharmaceuticals Inc | <0.01% | 99.8% |
| 372 | EMBCEmbecta Corp | <0.01% | 99.8% |
| 373 | KROSKeros Therapeutics Inc | <0.01% | 99.8% |
| 374 | RXSTRxSight Inc | <0.01% | 99.8% |
| 375 | VSTMVerastem Inc | <0.01% | 99.8% |
| 376 | ACHAccendra Health Inc | <0.01% | 99.8% |
| 377 | TMCITreace Medical Concepts Inc | <0.01% | 99.8% |
| 378 | ALECAlector Inc | <0.01% | 99.8% |
| 379 | ORGOOrganogenesis Holdings Inc | <0.01% | 99.8% |
| 380 | MULTIPLAN CORP | <0.01% | 99.8% |
| 381 | LYELLyell Immunopharma Inc | <0.01% | 99.8% |
| 382 | TRDAEntrada Therapeutics Inc | <0.01% | 99.8% |
| 383 | QTRXQuanterix Corp | <0.01% | 99.8% |
| 384 | HRTXHeron Therapeutics Inc | <0.01% | 99.8% |
| 385 | MXCTMaxCyte Inc | <0.01% | 99.8% |
| 386 | NMRANeumora Therapeutics Inc | <0.01% | 99.8% |
| 387 | KRROKorro Bio Inc | <0.01% | 99.8% |
| 388 | ALDXAldeyra Therapeutics Inc | <0.01% | 99.8% |
| 389 | LENZLENZ Therapeutics Inc | <0.01% | 99.8% |
| 390 | HCATHealth Catalyst Inc | <0.01% | 99.8% |
| 391 | FLNAFilana Therapeutics Inc | <0.01% | 99.8% |
| 392 | ALXOALX Oncology Holdings Inc | <0.01% | 99.8% |
| 393 | PLRXPliant Therapeutics Inc | <0.01% | 99.8% |
| 394 | DCGODocGo Inc | <0.01% | 99.8% |
| 395 | GOSSGossamer Bio Inc | <0.01% | 99.8% |
| 396 | DHDefinitive Healthcare Corp | <0.01% | 99.8% |
Funds that hold the most of the same stocks
The share of VHT that is also in each fund, from the positions both report. Open a fund for its own page, or the overlap figure to compare the two.
| Fund | Overlap | Shared |
|---|---|---|
| IYHiShares U.S. Healthcare ETF | 86.7% | 94 |
| XLVState Street(R) Health Care Select Sector SPDR(R) ETF | 85.4% | 59 |
| IXJiShares Global Healthcare ETF | 70.8% | 58 |
| HDViShares Core High Dividend ETF | 20.8% | 7 |
| VIGVANGUARD DIVIDEND APPRECIATION INDEX FUND | 17.7% | 26 |
| DGROiShares Core Dividend Growth ETF | 17.7% | 28 |
| IBBiShares Biotechnology ETF | 17.6% | 170 |
| SCHDSchwab U.S. Dividend Equity ETF | 16.0% | 5 |
Questions people ask
What are the top holdings of VHT?
Its filing lists 396 stock positions. The largest are LLY 14.0%, JNJ 8.5%, ABBV 6.1%, and the ten largest together are 51.9% of the fund. The full list with weights is on this page.
How many stocks are in VHT?
VHT reports 396 stock positions in its SEC filing of May 31, 2026, and together they are 100% of the fund. Cash, futures and bonds the fund holds are not counted.
How do I check whether VHT holds a particular stock?
Search the full list on this page by ticker or company name, for example NVDA or Nvidia. A stock the fund holds shows with its weight and its rank in the fund. If it does not show, the fund did not report it as a position in this filing.
How often do these holdings change?
Funds report their positions to the SEC at each quarter end, and the SEC publishes the filing about 60 days later. Ploutos reads the latest one every week, so the page changes four times a year, and shows the date of the filing it reads.
Why does the coverage not reach 100%?
The list is the stock positions the fund reports. Cash, futures, bonds and other assets the filing carries are not listed, and what the stocks add up to is the coverage shown. A stock fund lands near 100; a fund that holds futures or a cash sleeve lands lower. Weights are of the whole fund.
Compare VHT with another fund·All fund pairs
Descriptive data from public SEC filings. Nothing on this page is a recommendation to buy, sell or hold any fund or stock, and holdings change between filings.